Milestone Pharmaceuticals Inc.
MIST
$1.69
-$0.01-0.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.86M | 15.55M | 8.41M | 5.65M | 6.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.53M | 20.52M | 12.35M | 9.62M | 9.66M |
| Operating Income | -12.53M | -20.52M | -12.35M | -9.62M | -9.66M |
| Income Before Tax | -12.97M | -20.76M | -12.36M | -9.44M | -9.36M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.97M | -20.76M | -12.36M | -9.44M | -9.36M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.97M | -20.76M | -12.36M | -9.44M | -9.36M |
| EBIT | -12.53M | -20.52M | -12.35M | -9.62M | -9.66M |
| EBITDA | -12.50M | -20.50M | -12.32M | -9.59M | -9.64M |
| EPS Basic | -0.20 | -0.31 | -0.19 | -0.14 | -0.14 |
| Normalized Basic EPS | -0.12 | -0.20 | -0.12 | -0.09 | -0.09 |
| EPS Diluted | -0.20 | -0.31 | -0.19 | -0.14 | -0.14 |
| Normalized Diluted EPS | -0.12 | -0.20 | -0.12 | -0.09 | -0.09 |
| Average Basic Shares Outstanding | 66.38M | 66.29M | 66.27M | 66.19M | 66.17M |
| Average Diluted Shares Outstanding | 66.38M | 66.29M | 66.27M | 66.19M | 66.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |